This document provides an overview and forecast for the global tigecycline market from 2016 to 2021. It segments the market by application, bacteria type, and geography. Tigecycline is an antibiotic derivative of tetracycline that is effective against both gram-positive and gram-negative bacteria, including multi-drug resistant strains. The Asia-Pacific region currently dominates the market. Key players profiled include Roche Holdings, Johnson & Johnson, and Sanofi SA. The report also provides customization options and contact information for the sales manager.

1. Tigecycline Market
Forecast Report (2016-2021)
Contact:
Venkateshwar Reddy
sales@industryarc.com
#: +1-614-588-8538 (Ext: 101)

2. Report Segments
• By Applications
Skin & Soft Tissue Infections, Complicated Intra-
abdominal Infections, and Community-acquired
Bacterial Infection
• ByTarget BacteriaType
Gram Positive and Gram Negative
• By Geography

3. Overview
Tigecycline is an antibiotic derivative of tetracycline and
hence its structural attributes have extended its remedial
effectiveness to incorporate Gram-negative and Gram-
positive microorganisms, containing those of multi-drug
resistance.The expanding interest for tigecycline package
insert as an antibiotic is anticipated to fuel theTigecycline
Market over the next few years.

4. Regional Effect
The Asia-Pacific region is expected to hold on to its
dominant position till the end of the forecast period. On
the other hand, the European and North American
regions are expected to register a solid rate of growth in
the Tigecycline Market over the next few years.

5. Key players profiled in this report are:
• Roche Holdings
• Johnson & Johnson
• Sanofi SA
• Lifecare Innovations Pvt. Ltd.
• Progen Nutraceuticals Pvt. Ltd.

6. Tigecycline Market is highlighted with Competitive
landscape for each of the product types and market
players are profiled with attributes of company overview,
financial overview, business strategies, product portfolio
and recent developments.
Learn More About the Report
@
http://industryarc.com/Report/15303/tigecycline-
market.html

7. You Can Customize the Report as PerYour Need.
We have included Some Customization Options:
i. Company Profile
ii. Analyst Briefing
iii. Data Tables
iv. Key Contacts
v. Free Customization
Download PDF
Brochure
Inquiry Before
Buying

8. For More Details, Contact
Mr. Venkateshwar Reddy
Sales Manager
#: +1-614-588-8538 (Ext: 101)
Email: sales@industryarc.com
Connect with us on LinkedIn@
http://www.linkedin.com/company/industryarc